ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Ridge1
|
13K |
6.2M |
2 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
13K
|
6.2M
|
2
|
|
ASX - By Stock
|
ALA |
Re:
Breakout Looming?
|
|
Ridge1
|
349 |
152K |
3 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
349
|
152K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Ridge1
|
22K |
11M |
6 |
01/10/23 |
01/10/23 |
ASX - By Stock
|
22K
|
11M
|
6
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Ridge1
|
31K |
15M |
1 |
21/09/23 |
21/09/23 |
Charts
|
31K
|
15M
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Ridge1
|
31K |
15M |
4 |
21/09/23 |
21/09/23 |
Charts
|
31K
|
15M
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Receives Positive Feedback From FDA
|
|
Ridge1
|
115 |
46K |
7 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
115
|
46K
|
7
|
|
ASX - By Stock
|
IMU |
President Biden’s 2016 pledge for faster U.S, approval for cancer drug cocktails
|
|
Ridge1
|
0 |
304 |
4 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
0
|
304
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA clears Imugene IND for onCARlytics first-in-class study
|
|
Ridge1
|
148 |
65K |
0 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
148
|
65K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Images and Follows CHECKVacc in TNBC Patients
|
|
Ridge1
|
117 |
62K |
0 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
117
|
62K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
A famous beneficiary of Keytruda. Gained 6 more years. Keytruda PLUS Imugene drug now trialling
|
|
Ridge1
|
2 |
1.7K |
14 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
2
|
1.7K
|
14
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
Ridge1
|
1.0K |
633K |
2 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
1.0K
|
633K
|
2
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
Ridge1
|
1.0K |
633K |
15 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
1.0K
|
633K
|
15
|
|
ASX - By Stock
|
IMU |
A famous beneficiary of Keytruda. Gained 6 more years. Keytruda PLUS Imugene drug now trialling
|
|
Ridge1
|
2 |
1.7K |
17 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
2
|
1.7K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor Presentation, 14 March 2023
|
|
Ridge1
|
145 |
69K |
3 |
20/03/23 |
20/03/23 |
ASX - By Stock
|
145
|
69K
|
3
|
|
ASX - By Stock
|
CBA |
Re:
CBA back to $45-50 again soon?
|
|
Ridge1
|
643 |
287K |
1 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
643
|
287K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
The Glypromate failure
|
|
Ridge1
|
75 |
28K |
10 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
75
|
28K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Ridge1
|
22K |
11M |
6 |
15/01/23 |
15/01/23 |
ASX - By Stock
|
22K
|
11M
|
6
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
Ridge1
|
1.6K |
823K |
2 |
26/09/22 |
26/09/22 |
Charts
|
1.6K
|
823K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Preclinical trial of ALA iNKT therapy and IMU onCARlytics
|
|
Ridge1
|
75 |
42K |
1 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
75
|
42K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
CEO Exclusive - IMU doses first patient in phase one trial
|
|
Ridge1
|
105 |
126K |
5 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
105
|
126K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Ridge1
|
22K |
11M |
2 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
22K
|
11M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Ridge1
|
22K |
11M |
13 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
22K
|
11M
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Ridge1
|
22K |
11M |
34 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
22K
|
11M
|
34
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Ridge1
|
13K |
6.2M |
12 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
13K
|
6.2M
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Ridge1
|
13K |
6.2M |
37 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
13K
|
6.2M
|
37
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Ridge1
|
31K |
15M |
0 |
19/05/22 |
19/05/22 |
Charts
|
31K
|
15M
|
0
|
|
Charts
|
IMU |
Re:
For those that continue to bash Leslie Chong....
|
|
Ridge1
|
31 |
15K |
6 |
10/05/22 |
10/05/22 |
Charts
|
31
|
15K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW announces positive XanaMIA results for Xanamem
|
|
Ridge1
|
33 |
17K |
1 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
33
|
17K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Yesterday's example of US $1Billion offer for an Alzeimers drug Biotech
|
|
Ridge1
|
47 |
25K |
3 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
47
|
25K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Yesterday's example of US $1Billion offer for an Alzeimers drug Biotech
|
|
Ridge1
|
47 |
25K |
1 |
27/03/22 |
27/03/22 |
ASX - By Stock
|
47
|
25K
|
1
|
|
Charts
|
ACW |
Re:
Chart
|
|
Ridge1
|
267 |
128K |
1 |
22/03/22 |
22/03/22 |
Charts
|
267
|
128K
|
1
|
|
Charts
|
ACW |
Re:
Chart
|
|
Ridge1
|
267 |
128K |
1 |
22/03/22 |
22/03/22 |
Charts
|
267
|
128K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Yesterday's example of US $1Billion offer for an Alzeimers drug Biotech
|
|
Ridge1
|
47 |
25K |
2 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
47
|
25K
|
2
|
|
ASX - General
|
|
The Death of an Exchange
|
|
Ridge1
|
0 |
252 |
0 |
20/03/22 |
20/03/22 |
ASX - General
|
0
|
252
|
0
|
|
ASX - By Stock
|
ACW |
Yesterday's example of US $1Billion offer for an Alzeimers drug Biotech
|
|
Ridge1
|
47 |
25K |
7 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
47
|
25K
|
7
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen appoints Prof Paul Rolan as Chief Medical Officer
|
|
Ridge1
|
5 |
2.7K |
6 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
5
|
2.7K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Ridge1
|
9.9K |
4.4M |
15 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
9.9K
|
4.4M
|
15
|
|
ASX - By Stock
|
BRN |
World leading Medical Journal Lancet article on AI
|
|
Ridge1
|
6 |
3.3K |
10 |
12/02/22 |
12/02/22 |
ASX - By Stock
|
6
|
3.3K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Ridge1
|
9.9K |
4.4M |
1 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
9.9K
|
4.4M
|
1
|
|
ASX - By Stock
|
IMU |
Cashed up PFIZER seeking @Oncology, vaccines, rare diseases and internal medicine
|
|
Ridge1
|
0 |
971 |
48 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
0
|
971
|
48
|
|
Charts
|
IMU |
Re:
ASX need to investigate dodgy trading
|
|
Ridge1
|
6 |
4.3K |
2 |
04/02/22 |
04/02/22 |
Charts
|
6
|
4.3K
|
2
|
|
ASX - By Stock
|
BRN |
Re:
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection
|
|
Ridge1
|
110 |
49K |
10 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
110
|
49K
|
10
|
|
ASX - By Stock
|
BRN |
Re:
2022 BRN Discussion
|
|
Ridge1
|
10K |
4.7M |
0 |
15/01/22 |
15/01/22 |
ASX - By Stock
|
10K
|
4.7M
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Ridge1
|
22K |
11M |
4 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
22K
|
11M
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
Ridge1
|
75 |
45K |
2 |
08/01/22 |
08/01/22 |
ASX - By Stock
|
75
|
45K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Was Pfizer IMU's AGM's mystery huge vote production that removed a Director?
|
|
Ridge1
|
34 |
22K |
13 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
34
|
22K
|
13
|
|
ASX - By Stock
|
IMU |
Was Pfizer IMU's AGM's mystery huge vote production that removed a Director?
|
|
Ridge1
|
34 |
22K |
80 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
34
|
22K
|
80
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer
|
|
Ridge1
|
252 |
135K |
7 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
252
|
135K
|
7
|
|
Charts
|
IMU |
From the Professor ....
|
|
Ridge1
|
3 |
4.1K |
5 |
27/09/21 |
27/09/21 |
Charts
|
3
|
4.1K
|
5
|
|
Political Debate
|
|
ASIC warns ‘pump and dump’ share tactics could lead to fines and jail time
|
|
Ridge1
|
2 |
669 |
1 |
25/09/21 |
25/09/21 |
Political Debate
|
2
|
669
|
1
|
|